Abstract
INTRODUCTION: Warfarin is still anticoagulant of choice for many patients.Therapeutic time in range (TTR) is used to assess quality of warfarin anticoagulation. A TTR of above approximately 60% has been show to improve mortality and reduce risk of complications.Our hypothesis was the creation of a resident Anticoagulation Champion (AC) would be more efficacious than individual provider driven anticoagulation in a primary care resident clinic.METHODS: To be the AC residents were given a lecture on warfarin anticoagulation and assigned to the AC role for 2 week intervals. Duties included monitoring the anticoagulation book, calling patient's for appointment reminders, education, following up INR's and prescribing. There were a total of 56 patient charts which were reviewed from April 2014- March 2016. Three were excluded for not having INR values recorded during the time period. Of the 53 patients included, 5 patients had INR goals of 2.5-3.5 and 48 patients INR goal was 2-3. When calculating TTR, this range was extended to 1.95-3.04 and 2.45-3.54 as dosage would not be adjusted at these values. Patients were classified as not therapeutic with sub therapeutic and supra therapeutic INR's. Data was then split into 2 time periods: pre-resident based (April 2014-March 2015) and with AC (April 2015-March 2016). We calculated TTR using the traditional method. We compared TTR by month, age and sex. Comparisons were analyzed with a t-test.RESULTS: Of the subjects included, 57% were male. Mean and Median ages of patients were 60.94 and 60.5 respectively with range from 31 to 90 years old. Twenty patients were >65 years. The highest and lowest INR's in this study were 6.22 and 0.92 respectively. A total of 415 INR values were recorded. Pre- AC there was 37 values and with AC 378 values. TTR for males was 56% and females 49%. Average TTR by age was 53.47% for those <65yo and 57.25% for >65 years old. 11 patients had data before and with AC. The TTR pre-AC was 49.52% and with AC was 55.83%. The p value was 0.37. TTR by month ranged from 37-74%.CONCLUSIONS: There was a dramatic improvement in frequency of INR monitoring with the initiation of AC as shown by an increase of INR values during this time period. There was also a trend of improvement in the TTR with AC, however it was not statistically significant likely secondary to the low sample size.CLINICAL IMPLICATIONS: This suggests warfarin anticoagulation could be more efficacious with implementation of an Anticoagulation Champion in resident based primary care clinics. DisclosuresNo relevant conflicts of interest to declare.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.